Core Viewpoint - The announcement highlights the risk of *ST Dongfang potentially facing mandatory delisting due to significant violations of laws and regulations, following abnormal stock trading fluctuations and an ongoing investigation by the China Securities Regulatory Commission (CSRC) [1][5][7]. Summary by Relevant Sections Abnormal Stock Trading - The company's stock experienced a cumulative decline of over 12% in closing prices over three consecutive trading days on March 21, 24, and 25, 2025, which qualifies as abnormal trading behavior according to the Shanghai Stock Exchange rules [4][5]. Risk of Mandatory Delisting - The company received a notice from the CSRC on June 21, 2024, indicating that it is under investigation for suspected violations related to information disclosure. This could lead to mandatory delisting if the investigation concludes that the company has committed significant violations [4][6][7]. - The CSRC's preliminary findings suggest that the company artificially inflated its business operations through fictitious transactions, leading to inflated revenue figures in its annual reports from 2020 to 2023, with discrepancies of 3.90 billion, 4.87 billion, 6.54 billion, and 824 million yuan respectively [6][9]. Financial Reporting Issues - The annual reports for 2020 to 2023 contained false records, with inflated revenues constituting 25.20%, 32.05%, 50.44%, and 13.56% of the reported figures for each respective year. The inflated costs were also significant, representing 23.74%, 29.57%, 45.43%, and 11.45% of the reported costs [6][7]. Company Response and Compliance - The company is committed to cooperating with the CSRC and will exercise its rights to defend against the allegations. It will also disclose any further developments as required [5][9]. - As of March 25, 2025, the company's stock price has been below 1 yuan for seven consecutive trading days, which could lead to termination of listing if it remains below this threshold for 20 consecutive days [5][11]. Operational Status - The company has confirmed that, aside from the disclosed issues, there have been no other significant changes in its operational status or external environment [7].

证券代码：600811 证券简称：*ST 东方 公告编号：临 2025-039 东方集团股份有限公司 股票交易异常波动暨公司股票可能被实施重大违法强制退市的 风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要风险提示： 1 东方集团股份有限公司（以下简称"公司"）因涉嫌信息披露违法违规，被中国证券 监督管理委员会（以下简称"中国证监会"）立案调查。公司于 2025 年 3 月 16 日收 到中国证监会《行政处罚事先告知书》（处罚字﹝2025﹞24 号），认定公司出于维持 农产品贸易市场占有率、满足融资需求以及业绩考核等目的，通过人为增加业务环节 或虚构业务链条等方式，长期开展农产品融资性贸易和空转循环贸易。上述虚假销售 业务导致 2020 年至 2023 年年度报告存在虚假记载。详见公司于 2025 年 3 月 17 日披 露的《东方集团股份有限公司关于收到中国证券监督管理委员会<行政处罚事先告知 书>的公告》（公告编号：临 2025-033）。 如根据正式的处罚决定书结论，公司触及重大违法强制退市情形，公司股 ...

Group 1 - The article highlights a list of companies facing various financial difficulties, including those under investigation, continuous losses, and potential delisting risks [2][5] - Approximately 200 companies are mentioned in the "latest risk warning stock list," indicating a significant concern regarding the stability of the A-share market [5][6] - The A-share market experienced a notable decline, with the CSI 2000 index dropping by 1.90%, reflecting investor anxiety and market volatility [5][6] Group 2 - In contrast, the U.S. stock market saw a significant rise, with the Dow Jones Industrial Average increasing by 597.97 points, or 1.42%, indicating a positive market reaction to adjustments in tariff policies by President Trump [6] - The Nasdaq index rose by 404.54 points, or 2.27%, while the S&P 500 index gained 100.01 points, or 1.76%, showcasing a robust performance in the U.S. market [6] - The Nasdaq Golden Dragon China Index showed a slight decline of 0.02%, reflecting the complex dynamics of U.S.-China trade relations and the contrasting sentiments in the two markets [6]

星标 ★ IPO日报 精彩文章第一时间推送 两家公司因为存在虚假记载，公司股票交易将被实施其他风险警示！ 3月23日晚间， 香雪制药 (300147)发布公告称，公司收到中国证监会发出的《行政处罚事先告知书》，因公司披露的2019年年度报 告存在虚假记载，公司股票交易将被实施其他风险警示，股票简称由"香雪制药"变更为"ST香雪"。 朗源股份 (300175)同一天披露公告称，近日收到山东证监局出具的《行政处罚事先告知书》，因公司2019年年度报告和更正公告存 在虚假记载，深圳证券交易所将对公司股票交易实施其他风险警示，股票简称由"朗源股份"变更为"ST朗源"。 制图：佘诗婕 存在虚假记载 具体来看，最新披露的《行政处罚事先告知书》显示，香雪制药2019年年度报告存在虚假记载。2019年12月，香雪制药位于广州生 物岛上5栋别墅被相关政府部门拆除香雪制药未按规定确认拆除别墅产生的在建工程损失，导致2019年年度报告虚增利润5383.25万 元，占当期披露利润总额的45.98%，2019年年度报告存在虚假记载。 另外，香雪制药未按规定披露关联方非经营性资金占用，2016年至2020年年度报告存在重大遗漏。2016 ...

证券代码：600811 证券简称：*ST 东方 公告编号：临 2025-038 东方集团股份有限公司 关于公司股票可能被实施重大违法强制退市的风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1 东方集团股份有限公司（以下简称"公司"）因涉嫌信息披露违法违规，被中国证券 监督管理委员会（以下简称"中国证监会"）立案调查。公司于 2025 年 3 月 16 日收 到中国证监会《行政处罚事先告知书》（处罚字﹝2025﹞24 号，以下简称"《告知 书》"），认定公司出于维持农产品贸易市场占有率、满足融资需求以及业绩考核等目 的，通过人为增加业务环节或虚构业务链条等方式，长期开展农产品融资性贸易和空 转循环贸易。上述虚假销售业务导致 2020 年至 2023 年年度报告存在虚假记载。详见 公司于 2025 年 3 月 17 日披露的《东方集团股份有限公司关于收到中国证券监督管理 委员会<行政处罚事先告知书>的公告》（公告编号：临 2025-033）。 如根据正式的处罚决定书结论，公司触及重大违法强制退市情形 ...

以下文章来源于金角财经 ，作者Chong Lei 金角财经 . 城市新中产读本，拆解经济事件背后的逻辑。 回顾过往，恒大、康美等财务造假大案中的审计机构，都因失职遭受了严厉惩处。值得警惕的是，作 为头部内资所的大华却重蹈覆辙，其执业质量屡遭监管警示。这引发出一个令人窒息的问题： 当系统性风险已然显现，为何专业机构的风控机制仍形同虚设？为何监管警示与市场预警不断发出， 却始终未能触动其整改决心？ 作者：Chong Lei,CFA 来源：金角财经（ID: F-Jinjiao) 大华会计师事务所，正深陷东方集团的造假风波。 不久前，证监会通报了东方集团财务造假案的最新进展，称后者披露的2020年至2023年财务信息严重 不实，涉嫌重大财务造假，可能触及重大违法强制退市情形。 "连续造假4年"震惊市场同时，作为东方集团的审计机构，大华的角色也被放至聚光灯下。 作为对东方集团审计多年的专业机构，大华在数年间，面对那些连普通投资者都能察觉的财务数据异 常，如过百亿高营收与极低毛利率的诡异矛盾，仿佛视而不见，连续给出"标准无保留"意见。这不禁 让人发问，大华究竟是专业能力不足，还是另有原因？ 此外，近年来，大华已多次出现在 ...

Core Viewpoint - The article highlights the significant issue of internal control failures in listed companies, which serve as a breeding ground for financial fraud, and emphasizes the need for a thorough examination of the auditing mechanisms and corporate governance systems in place [2][5]. Summary by Sections Financial Fraud Cases - Dongfang Group was fined millions by the CSRC for significant financial fraud, having inflated business revenue by over 16 billion yuan through fictitious business operations over four years [3]. - A staggering 80% of companies penalized by the CSRC had received unqualified audit opinions regarding their internal controls in the five years leading up to their penalties [4][8]. Audit Mechanisms and Internal Controls - The audit process is likened to a health check for a company, focusing on the compliance of financial reporting and internal controls [7]. - The Ministry of Finance and the CSRC issued guidelines in 2010 stating that any significant internal control deficiencies should lead to a negative audit opinion [7]. - Despite clear evidence of financial misconduct, many companies received standard unqualified opinions on their internal controls during the years of their violations [10][12]. Statistics on Audit Opinions - From 2022 onwards, 257 companies were penalized for financial reporting violations, with many having never received non-standard audit opinions in the five years prior [12][13]. - Among the companies that faced penalties, 178 had internal control audits that were deemed effective, despite their violations [13]. Discrepancies in Audit Findings - The article discusses the disconnect between audit opinions and regulatory penalties, attributing it to differences in the focus and capabilities of auditors versus regulatory bodies [17][18]. - Auditors often prioritize financial reporting over internal controls, leading to a lack of attention to potential internal control failures [18]. Recommendations for Improvement - To restore the credibility of audits, experts suggest enhancing auditor independence, adopting modern auditing techniques, and addressing low-cost competition that undermines audit quality [23][25][26]. - A comprehensive digital system is recommended to improve internal governance and reduce violations of internal control procedures [30]. - Cultivating a compliance culture within companies is essential, with suggestions for regular risk training and establishing a whistleblower system to encourage reporting of misconduct [31]. Conclusion - The article concludes that the effectiveness of internal controls is crucial for corporate governance, and there is an urgent need for companies to address the systemic issues that lead to audit failures and financial misconduct [28][29].

星标 ★ IPO日报 精彩文章第一时间推送 3月18日，由于2020年至2023年年度报告存在虚假记载，上交所上市公司 东方集团有限公司（下称" 东方集团"）依规被实施退市 风险警示，股票简称变更为*ST东方（600811），日涨跌幅限制为5%。 另一方面，公司股价在经历连续数日跌停后已触及1元退市红线。 3月18日，公司开盘即跌停并一直封死跌停板，收盘价为0.87元，已经 连续两个交易日低于1元"生死线"。 根据《股票上市规则》，如连续20个交易日的每日股票收盘价均低于1元，公司股票可能被交易所 终止上市交易。 这意味着，东方集团将面临重大违法退市及面值退市的双重退市危机。 制图：佘诗婕 这也意味着，东方集团在4年时间内虚增营业收入高达161.3亿元，虚增营业成本160.73亿元。 基于违法事实，证监会对东方集团相关责任人也作出了行政处罚。 其中，对东方集团股份有限公司责令改正，给予警告，并处以1000万元罚款；对张宏伟（实控人）处以1000万元罚款；对孙明涛（时任 总裁）给予警告，并处以500万元罚款；对党荣毅（时任财务总监）给予警告，并处以350万元罚款；对康文杰（时任董秘）给予警告， 并处以300万元 ...

Group 1 - The core point of the article is that Oriental Group has been subjected to a delisting risk warning due to significant financial fraud over the past four years, resulting in a change of its stock name to *ST Oriental with a daily price fluctuation limit of 5% [1] - During the delisting risk warning period, Oriental Group is required to disclose progress every five trading days and provide special risk warnings regarding major illegal activities leading to mandatory delisting [1] - Following the receipt of the administrative penalty decision, the company's stock will be suspended from trading, awaiting a decision on termination of its listing [1]

文/梧桐小新 3月16日晚，东方集团股份有限公司（东方集团，600811）发布公告，收到证监会《行政处罚事先告知书》。2020年至2023年， 东方集团出于维持农产品贸易市场 占有率、满足融资需求以及业绩考核等目的，通过人为增加业务环节或虚构业务链条等方式，长期开展农产品融资性贸易和空转循环贸易，连续四年财务造假， 累计虚增营业收入161.29亿元、虚增营业成本160.74亿元。 公司及8名相关责任人合计被罚3900万，其中董秘被罚300万，实控人、董事长被终身市场禁入。值得注 意的是，东方集团2020年至2023年年报均由大华会计师事务所审计，2020年至2022年均出具标准无保留意见。因触及上市规则中多项重大违法强制退市情形，东 方集团股票于2025年3月17日起停牌，2025年3月18日起复牌，自复牌之日实施退市风险警示。 此前，证监会曾于2月28日通报东方集团财务造假案阶段性调查进展情况：现已初步查明，东方集团披露的2020年至2023年财务信息严重不实，涉嫌重大财务造 假，可能触及重大违法强制退市情形。3月3日至14日，东方集团股价9个交易日跌停，3月14日收盘价为0.92元/股，低于人民币1元。 ...